End-to-end integrated fully continuous production of recombinant monoclonal antibodies.

J Biotechnol

Late Stage Process Development, Genzyme - A Sanofi Company, 45 New York Ave, Framingham, MA 01701, USA. Electronic address:

Published: November 2015

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jbiotec.2015.06.393DOI Listing

Publication Analysis

Top Keywords

end-to-end integrated
4
integrated fully
4
fully continuous
4
continuous production
4
production recombinant
4
recombinant monoclonal
4
monoclonal antibodies
4
end-to-end
1
fully
1
continuous
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!